Corient Private Wealth LP bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,683,612 shares of the company’s stock, valued at approximately $322,538,000. Corient Private Wealth LP owned about 2.08% of Merck KGaA as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Frazier Financial Advisors LLC purchased a new stake in shares of Merck KGaA during the 2nd quarter worth approximately $25,000. Rakuten Securities Inc. purchased a new position in Merck KGaA in the second quarter valued at approximately $27,000. Delos Wealth Advisors LLC purchased a new position in Merck KGaA in the second quarter valued at approximately $33,000. Solstein Capital LLC bought a new position in Merck KGaA during the second quarter valued at $33,000. Finally, Burk Holdings LLC bought a new position in Merck KGaA during the second quarter valued at $39,000. 0.10% of the stock is owned by institutional investors.
Merck KGaA Stock Performance
OTCMKTS:MKGAF opened at $164.58 on Thursday. The company has a market capitalization of $21.27 billion, a P/E ratio of 25.13 and a beta of 0.96. The business has a fifty day simple moving average of $163.19 and a two-hundred day simple moving average of $148.83. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
